Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: Summary findings of an independent panel

Journal of Clinical Oncology

Volumn 19, Issue 18, 2001, Pages 3801-3807

  Rothenberg, M L ^a   Meropol, N J ^a   Poplin, E A ^a   Van Cutsem, E ^a   Wadler, S ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ABDOMINAL CRAMP; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CLINICAL TRIAL; COLORECTAL CANCER; DEHYDRATION; DIARRHEA; DISEASE EXACERBATION; DRUG FATALITY; ELECTROLYTE DISTURBANCE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKEMIA; NAUSEA; NEUTROPENIA; PATIENT MONITORING; PRIORITY JOURNAL; THROMBOEMBOLISM; VASCULAR DISEASE; VOMITING;

EID: 0035884212     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.18.3801     Document Type: Article

References (13)

1. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
2. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
3. Oxaliplatin or CPT-11 combined with 5FU/Leucovorin in advanced colorectal cancer: An NCCTG/CALGB study
4. Multicenter Phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen
5. Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: Results of two independent Phase I studies with pharmacokinetics
6. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: A prospective randomized Phase III trial
7. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
8. Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the 1-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer
9. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected Stage III colon cancer: Results of the trial adjCCA-01
10. Clinical trial to assess the relative efficacy of fluorouracil and luecovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04
11. Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)
12. Rapid reporting and review of an increased incidence of a known adverse event